Clinical Trial Update: Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update of Seraprevir combined with Sofosbuvir in adults with chronic Hepatitis C Virus infection (genotypes 2, 3, and 6).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Seraprevir (Seraprevir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Ginkgopharma CO., LTD | Conditions: Hepatitis C Virus Infection | Phase 2 | Status: UNKNOWN